Phase 3 vaccine to prevent invasive E.coli infection the leading bacteria in urinary tract infections. Ages 60 and over both male and females that have had at least one urinary tract infection in the last two years. Documentation of the UTI will be required prior to vaccination. The study will last two years with 8 office visits to the clinic. Compensation for time and travel will be provided up to $600.
Urinary Tract Infection Vaccine
This study is currently active